ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Nikkei Markets

Hong Kong's Hang Seng Index tops 27,000 after US stocks set highs

HSBC climbs after report on restructuring, including senior management job cuts

HONG KONG (Nikkei Markets) -- Hong Kong shares looked set to stretch their rally on Thursday, sending the Hang Seng Index above the 27,000-point-level for the first time in a week, as record highs for stocks on Wall Street and speculation of support from mainland investors helped buoy sentiment.

The Hang Seng Index advanced 2% to 27,312.45 by noon, heading for its highest close since Dec. 24. HSBC Holdings added 1.6%. The London-headquartered lender is set to unveil a plan to cut some senior international management jobs and reduce its presence in some smaller markets, Reuters reported, citing people with knowledge of the matter. Separately, Reuters cited a staff memo as saying the bank plans to ban all staff travel to Hong Kong until March 2 due to the coronavirus outbreak.

China Petroleum & Chemical rose 3.4% and offshore oil producer CNOOC added 4.3%, as Brent crude futures headed for a second day higher following a 2.4% increase on Wednesday. CNOOC is lowering crude oil throughput this month at its Huizhou plant in China's Guangdong Province by about 8% from its original plan, as the coronavirus has cut demand for refined fuel, Reuters reported, citing a company source.

Instant-noodle maker Nissin Foods jumped 4.9%, extending a 4.8% climb on Wednesday, while toilet-paper maker Vinda International Holdings added 2.8% to its recent advances on speculation they would benefit as people stocked up on essentials amid the outbreak.

The S&P 500 Index and the Nasdaq Composite closed at record highs on Wednesday following upbeat jobs and business activity data from the world's largest economy. Still, worries over the widespread impact of the coronavirus gripped markets. Hong Kong has confirmed 21 cases of infections as of Wednesday and one fatality. In China, the death toll has reportedly crossed 560 people, while more than 28,000 cases of the infection have been confirmed.

"I think the rebound is near completion," said Kevin Leung, executive director for investment strategy at Haitong International Securities, referring to the recent stock advances. "Firstly, there is some short covering. Secondly, mainland capital is trying to stabilize things."

Leung said he expects "panic selling" to only last "maybe a few months" and that he is not too worried about the rest of the year.

Pine Care Group surged 86.3% after the elderly home-care services provider said Pine Active Care was selling 52% of its stake in the company to Tang Yiu Sing for 773.3 million Hong Kong dollars ($99.6 million). Following the sale, Tang Yiu Sing will own a 52.55% stake in the firm, triggering a possible mandatory cash offer for company.

Shares of China Medical System Holdings were suspended on Thursday after short-seller Blue Orca issued a report on the drugmaker, alleging financial impropriety and inflated profits. The stock was down 1.9% when trading was halted after falling more than 10% earlier.

Blue Orca said it has a short position in CMS, alleging that its investigation found a "rotten pattern of undisclosed self-dealing." A call and an email to CMS's investor relations department seeking a comment were not immediately answered.

Mainland property developer China Vanke advanced 2.3% following a 12.3% increase in January contracted sales from a year earlier.

KWG Group rose 3.4% after reporting a 1.2% increase in presales value for January.

Mining company China Hanking Holdings added 3.1% after saying it expects net profit for the year ended Dec. 31 to have risen 50% from a year ago.

Sany Heavy Equipment International added 2.2% after the company said it expects profit for the year ended Dec 31 to have risen 45% to 55% from a year ago.

-- Benny Kung

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more